Stay updated on RGN-259 Ophthalmic Solutions for Dry Eye Syndrome Clinical Trial

Sign up to get notified when there's something new on the RGN-259 Ophthalmic Solutions for Dry Eye Syndrome Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the RGN-259 Ophthalmic Solutions for Dry Eye Syndrome Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0. The page continues to show a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-11-01T15:42:53.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    A sitewide banner announces NIH website updates and says NIH content may use “Super Intelligence” alongside “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-25T15:28:55.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now displays revision v3.7.2 instead of v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-18T22:08:49.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1. The page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T22:00:54.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error instead of the study record, with a minimal header/footer indicating an access restriction. This replaces the detailed trial information with an error page, affecting the core purpose of the page.
    Difference
    19%
    Check dated 2026-09-20T20:38:10.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    ARISE-3 results have been posted and the study record now includes updated inclusion/exclusion criteria. In addition, several outcomes and related data fields have been added or revised, aligning the record with the latest study documentation.
    Difference
    6%
    Check dated 2026-08-30T15:42:09.000Z thumbnail image

Stay in the know with updates to RGN-259 Ophthalmic Solutions for Dry Eye Syndrome Clinical Trial

Enter your email address, and we'll notify you when there's something new on the RGN-259 Ophthalmic Solutions for Dry Eye Syndrome Clinical Trial page.